Novartis sues Cipla over infringement of Onbrez patents: HC reserves judgement
Close on the heels of the health ministry’s statement regarding patent revocation, Novartis has sued Cipla for infringing patents covering Onbrez (Indacaterol-drug used to treat chronic obstructive pulmonary disease) and sought damages. Onbrez is protected by 5 patents in India – IN222346 (product patent- expiring in 2020); IN214320 (composition patent- expiring in 2021); IN230049, IN210047 and IN230312 (process patents- expiring in 2024). Earlier last month Cipla had launched a low cost generic version of Onbrez and petitioned to DIPP requesting […]
Novartis sues Cipla over infringement of Onbrez patents: HC reserves judgement Read More »







